Nasal Carbon Dioxide for the Symptomatic Treatment of Classical Trigeminal Neuralgia
Status:
Completed
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
A placebo-controlled, single-blind study to evaluate the safety and preliminary efficacy of
nasal carbon dioxide for the symptomatic treatment of classical trigeminal neuralgia.